Shanxi Zhendong Pharmaceutical Co.,Ltd (SHE:300158)
China · Delayed Price · Currency is CNY 5.74
+0.02 (0.35%)
Apr 29, 2026, 3:04 PM CST
SHE:300158 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -305.29 | -303.09 | -1,329 | -43.98 | -51.29 | 2,617 |
Depreciation & Amortization | 115.99 | 115.99 | 108.9 | 121.68 | 126.01 | 125.13 |
Other Amortization | 11.85 | 11.85 | 11.16 | 8.81 | 21.04 | 23.04 |
Loss (Gain) From Sale of Assets | 0.63 | 0.63 | -11.26 | 0.29 | 0.54 | -0 |
Asset Writedown & Restructuring Costs | 4.15 | 4.15 | 44.22 | 7.62 | 0.94 | 13.64 |
Loss (Gain) From Sale of Investments | -10.78 | -10.78 | 97.47 | -45.04 | -66.05 | -2,954 |
Provision & Write-off of Bad Debts | - | - | -5.32 | -20.16 | -14.04 | -6.83 |
Other Operating Activities | 30.36 | 2.21 | 252.21 | 28.66 | -19.73 | 33.74 |
Change in Accounts Receivable | -164.54 | -164.54 | 115 | 97.98 | 319.57 | 303.08 |
Change in Inventory | 237.15 | 237.15 | 176.5 | -132.44 | -141.24 | -163.18 |
Change in Accounts Payable | -347.97 | -347.97 | 270.36 | -266.99 | -78.98 | 320.12 |
Change in Income Taxes | - | - | - | - | -4.98 | - |
Change in Other Net Operating Assets | -3.09 | -3.09 | 122.77 | -3.75 | -15.42 | -39 |
Operating Cash Flow | -434.53 | -460.48 | -149.82 | -249.17 | 81.32 | 284.45 |
Operating Cash Flow Growth | - | - | - | - | -71.41% | 28.16% |
Capital Expenditures | -172.11 | -179.12 | -298.48 | -116.21 | -145.81 | -151.66 |
Sale of Property, Plant & Equipment | 0.06 | 0.06 | 7.77 | - | 1.09 | - |
Divestitures | - | - | 0.99 | - | - | 4,961 |
Investment in Securities | 105.4 | 462.9 | 282.26 | 529.83 | 2,464 | -4,462 |
Other Investing Activities | 11.57 | 12.87 | 46.97 | 59.22 | 77.77 | 2.24 |
Investing Cash Flow | -55.07 | 296.7 | 39.51 | 472.84 | 2,397 | 348.85 |
Short-Term Debt Issued | - | - | 38.11 | 0.1 | - | - |
Long-Term Debt Issued | - | 162.16 | - | - | 80 | 424.68 |
Total Debt Issued | 310.54 | 162.16 | 38.11 | 0.1 | 80 | 424.68 |
Short-Term Debt Repaid | - | - | -53.35 | -21 | - | - |
Long-Term Debt Repaid | - | -33.97 | -0.65 | -0.65 | -379.55 | -630.48 |
Total Debt Repaid | -33.82 | -33.97 | -54 | -21.65 | -379.55 | -630.48 |
Net Debt Issued (Repaid) | 276.73 | 128.19 | -15.89 | -21.55 | -299.55 | -205.8 |
Issuance of Common Stock | - | - | - | - | 718.3 | 1.64 |
Repurchase of Common Stock | - | - | -105.59 | -21.82 | -586.6 | - |
Common Dividends Paid | -1.64 | -0.71 | -0.58 | -1.22 | -2,786 | -195.09 |
Other Financing Activities | 11.8 | -29.85 | 27.57 | -99.98 | -24.6 | 12.8 |
Financing Cash Flow | 286.89 | 97.63 | -94.49 | -144.57 | -2,979 | -386.46 |
Net Cash Flow | -202.72 | -66.15 | -204.8 | 79.1 | -500.4 | 246.84 |
Free Cash Flow | -606.64 | -639.6 | -448.3 | -365.39 | -64.49 | 132.79 |
Free Cash Flow Growth | - | - | - | - | - | 249.58% |
Free Cash Flow Margin | -22.66% | -22.98% | -15.09% | -10.08% | -1.73% | 2.61% |
Free Cash Flow Per Share | -0.61 | -0.64 | -0.44 | -0.36 | -0.06 | 0.13 |
Cash Income Tax Paid | 159 | 159 | 183.41 | 311.27 | 208.63 | 492.35 |
Levered Free Cash Flow | -294.68 | -373.14 | 297.03 | -389.2 | 109.14 | 525.38 |
Unlevered Free Cash Flow | -294.34 | -373.14 | 299.47 | -388.44 | 117.75 | 537.65 |
Change in Working Capital | -281.45 | -281.45 | 681.36 | -307.04 | 83.9 | 432.45 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.